Revium Rx. operates as a pre-clinical stage biopharmaceutical company focused on the development of nanoparticle-based therapies in the United States. The company develops lipid-based platforms for a variety of uses including antimicrobial resistance and solid tumors; specializes in infectious disea... Revium Rx. operates as a pre-clinical stage biopharmaceutical company focused on the development of nanoparticle-based therapies in the United States. The company develops lipid-based platforms for a variety of uses including antimicrobial resistance and solid tumors; specializes in infectious diseases, including antibiotic-resistant infections, solid tumors, and vaccination; and develops nano-liposomal particles (NLP) based pharmaceutical candidates. It also offers Nano-Mupirocin, a NLP-based formulation of potent antibiotic mupirocin. In addition, the company develops nanoparticles-based formulation of an angiotensin receptor blockers; novel adjunct for cancer therapies: and novel immunization based on liposomal protein-loaded technology. The company was formerly known as Revium Recovery Inc. and changed its name to Revium Rx. in December 2024. Revium Rx. was incorporated in 1997 and is headquartered in Herzliya, Israel. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 1.67 | 1.67 | 1.67 | 25 | 1.67 | CS |
| 26 | 0.62 | 59.0476190476 | 1.05 | 1.67 | 1.05 | 145 | 1.5148401 | CS |
| 52 | 1.15 | 221.153846154 | 0.52 | 1.67 | 0.52 | 69 | 1.30945816 | CS |
| 156 | 0.17 | 11.3333333333 | 1.5 | 1.67 | 0.3 | 79 | 1.08013712 | CS |
| 260 | -0.64 | -27.7056277056 | 2.31 | 2.31 | 0.3 | 76 | 1.22029376 | CS |
splintered sunlight
3日前
splintered sunlight
4日前
splintered sunlight
8月前
splintered sunlight
5年前
splintered sunlight
5年前
ADenn
5年前
ADenn
5年前
ADenn
5年前
JP313
5年前
JP313
6年前
cornhole
6年前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。